Biotech International Limited Reports Strong FY2025 Performance
• Biotech International Limited, a New Delhi-based biotechnology company specializing in agriculture and public health, reported revenue between INR 100-150 crore for the financial year ending March 31,
• The company's performance was driven by strong demand for its biological crop protection, nutrition management, and biolarvicide products. Established in 1993, Biotech International Limited has over three decades of experience in the biotechnology sector and operates a state-of-the-art manufacturing facility with significant production capacity. The company’s products are not only widely used across India but are also registered in various countries in Africa, the Middle East, South America, and Europe. The company is led by Managing Director Saurabh Singhal, a veteran in the field of biological agriculture.
Impact & Risks
The strong financial performance of Biotech International Limited highlights the growing adoption of sustainable agricultural practices in India and abroad. Farmers and public health sectors benefit from the company's innovative products, which address pest control, crop nutrition, and disease management. However, the company faces challenges such as maintaining quality standards while scaling up production and navigating regulatory requirements in international markets. Any disruption in supply chains or regulatory hurdles could impact its growth trajectory.
Related News